Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01296932
Title BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | DEU | BEL


No variant requirements are available.